{
    "SPADE_UN_15208": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_15208",
            "Peptide Name": "Pep19-2.5",
            "Source": "Synthetic construct",
            "Family": "Retroviridae,Herpesviridae, Flaviviridae, Hepadnaviridae",
            "Gene": "Not found",
            "Sequence": "GCKKYRRFRWKFKGKFWFWG",
            "Sequence Length": 20,
            "UniProt Entry": "No entry found",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Antimicrobial",
                "Antiviral"
            ],
            "Target Organism": "[Ref.22457281]HIV-1 BaL:inhibition of viral entry in 293T cells(IC50=8 µg/ml);HIV-1 NL4-3:inhibition of viral entry in 293T cells(IC50=16 µg/ml);HSV-1:inhibition of viral entry in Vero cells(IC50=0.42 µg/ml);Hepatitis C virus (HCV):inhibition of viral entry in 293T cells(IC50=40 µg/ml);Hepatitis B virus (HBV):inhibition of viral entry in 293T cells(IC50=1 µg/ml).",
            "Hemolytic Activity": "No hemolysis information or data found in the reference(s) presented in this entry",
            "Cytotoxicity": "[Ref.22457281]No significant cytotoxicity to Vero, TZM-bl and Jurkat cells even at a high concentration of 20 μg/mL.",
            "Binding Target": "membrane",
            "Linear/Cyclic": "Linear",
            "N-terminal Modification": "Free",
            "C-terminal Modification": "Free",
            "Stereochemistry": "L",
            "Structure Description": "Not found",
            "Formula": "C135H187N37O22S",
            "Mass": 2712.23,
            "PI": 11.17,
            "Net Charge": 8,
            "Hydrophobicity": -1.23,
            "Half Life": "Mammalian:30 hourYeast:>20 hourE.coli:>10 hour",
            "Mechanism of action": "SALPs block entry of a variety of human pathogenic enveloped viruses, such as HIV-1, HBV, HCV, and HSV 1 and 2 by blocking heparan sulfate on the host cell plasma membrane, which serves as a the docking molecule for these pathogens.",
            "Literature": [
                {
                    "Title": "A new class of synthetic peptide inhibitors blocks attachment and entry of human pathogenic viruses.",
                    "Pubmed ID": "22457281",
                    "Reference": "J Infect Dis. 2012 Jun;205(11)1654-64.",
                    "Author": "Krepstakies M, Lucifora J, Nagel CH, Zeisel MB, Holstermann B, Hohenberg H, Kowalski I, Gutsmann T, Baumert TF, Brandenburg K, Hauber J, Protzer U.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=22457281"
                }
            ],
            "Frequent Amino Acids": "KFG",
            "Absent Amino Acids": "ADEHILMNOPQSTUV",
            "Basic Residues": 8,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 8,
            "Polar Residues": 10,
            "Positive Residues": 8,
            "Negative Residues": 0,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_08460",
                    "Similarity": 1.0,
                    "Sequence": "GCKKYRRFRWKFKGKFWFWGG"
                },
                {
                    "SPADE_ID": "SPADE_N_08469",
                    "Similarity": 1.0,
                    "Sequence": "GCKKYRRFRWKFKGKFWFW"
                },
                {
                    "SPADE_ID": "SPADE_UN_27621",
                    "Similarity": 1.0,
                    "Sequence": "GCKKYRRFRWKFKGKFWFWGG"
                }
            ]
        }
    }
}